Kevin L Lorick from Silver Spring, MD, age 57

Resumes

Lead Interdisciplinary Scientist

view source

Location:

Silver Spring, MD

Industry:

Biotechnology

Work:

U.S. Food and Drug Administration since May 2009
Regulatory Scientist
The Green Cell Inc Oct 2008 - May 2009
Consulting Scientist and Founder
Intrexon Corporation Jun 2008 - Oct 2008
Senior Director Bioassay Design
Intrexon Corporation May 2007 - Jun 2008
Director of Subcellular Assays
Intrexon Dec 2006 - May 2007
Senior Cell Biologist

Education:

Tulane University 1992 - 1997
PhD, Molecular and Cellular Biology University of Chicago 1986 - 1990
SB, Biological Chemistry

Skills:

Biochemistry
Molecular Biology
Biotechnology
Cell Biology
Immunology
Cell
Protein Chemistry
Dna
Science
Lifesciences
Chemistry
In Vitro
Life Sciences
Cell Culture
R&D
Medical Devices
Pcr
Oncology
Laboratory
Regulatory Affairs
Research
Genetics
Bioinformatics
Protein Purification
Western Blotting
Glp
Elisa
Protein Expression
Product Development
Fda
Gmp
Cell Based Assays
Patents
Powerpoint
Data Analysis
Tissue Culture
Excel
Microsoft Office
Nanotechnology
Technical Writing
Sds Page

Interests:

Science and Technology
Health

Languages:

English
Spanish

Certifications:

Regulatory Affairs Certified (R.a.c.-Us Regulatory Affairs)
Regulatory Affairs Certified (R.a.c.-Global Regulatory Affairs)
Regulatory Affairs Certified (R.a.c.-European Union Regulatory Affairs)
Regulatory Afairs Professional Society
Regulatory Affairs Professionals Society (Raps)

Kevin Lorick

view source

Us Patents

Transgenic Aloe Plants For Production Of Proteins And Related Methods
view source
US Patent:

20120017336, Jan 19, 2012
Filed:

Jul 22, 2011
Appl. No.:

13/188815
Inventors:

William J. Lowther - Washington DC, US
Kevin Lorick - Kensington MD, US
Marisol Pages - Santo Domingo, DO
Nicola J. Lowther - Washington DC, US
Assignee:

TheGreenCell, Inc. - Miami FL
International Classification:

A01H 1/00
C12P 21/00
US Classification:

800288, 435 691, 435 694, 435 695, 435 696
Abstract:

The present inventions provide transgenic aloe plants and recombinant constructs for transforming aloe plants, aspects of which, may be applied to other monocots. The recombinant constructs may include one or more DNA sequences encoding mammalian proteins and at least one promoter capable of directing the expression of recombinant proteins in an aloe plant. The present inventions also provide methods for constructing and reproducing a transgenic aloe plant. The present inventions include methods for transfection of an aloe plant with several genes of interest simultaneously. The aloe plant production methods of the inventions may provide the potential to inexpensively and more safely mass-produce some biologically active compounds including biopharmaceuticals for disease therapy, diagnosis and prevention, and is more accessible to the less affluent countries. The aloe plant production methods may also produce proteins for cosmetics.

Transgenic Aloe Plants For Production Of Proteins And Related Methods
view source
US Patent:

20130061353, Mar 7, 2013
Filed:

Oct 30, 2012
Appl. No.:

13/663992
Inventors:

Kevin LORICK - Kensington MD, US
Marisol PAGES - Santo Domingo, DO
Nicola J. LOWTHER - Washington DC, US
Assignee:

THEGREENCELL, INC. - Miami FL
International Classification:

C12N 15/82
A01H 5/00
C12N 5/10
US Classification:

800298, 435419, 435468
Abstract:

The present inventions provide transgenic aloe plants and recombinant constructs for transforming aloe plants, aspects of which, may be applied to other monocots. The recombinant constructs may include one or more DNA sequences encoding mammalian proteins and at least one promoter capable of directing the expression of recombinant proteins in an aloe plant. The present inventions also provide methods for constructing and reproducing a transgenic aloe plant. The present inventions include methods for transfection of an aloe plant with several genes of interest simultaneously. The aloe plant production methods of the inventions may provide the potential to inexpensively and more safely mass-produce some biologically active compounds including biopharmaceuticals for disease therapy, diagnosis and prevention, and is more accessible to the less affluent countries. The aloe plant production methods may also produce proteins for cosmetics.

Transgenic Aloe Plants For Production Of Proteins And Related Methods
view source
US Patent:

8008546, Aug 30, 2011
Filed:

Sep 26, 2006
Appl. No.:

11/528056
Inventors:

William J. Lowther - Washington DC, US
Kevin Lorick - Kensington MD, US
Marisol Pages - Santo Domingo, DO
Nicola J. Lowther - Washington DC, US
Assignee:

TheGreenCell, Inc. - Miami FL
International Classification:

A01H 5/00
C12N 15/82
US Classification:

800298, 800295, 800288
Abstract:

The present inventions provide transgenic aloe plants and recombinant constructs for transforming aloe plants, aspects of which, may be applied to other monocots. The recombinant constructs may include one or more DNA sequences encoding mammalian proteins and at least one promoter capable of directing the expression of recombinant proteins in an aloe plant. The present inventions also provide methods for constructing and reproducing a transgenic aloe plant. The present inventions include methods for transfection of an aloe plant with several genes of interest simultaneously. The aloe plant production methods of the inventions may provide the potential to inexpensively and more safely mass-produce some biologically active compounds including biopharmaceuticals for disease therapy, diagnosis and prevention, and is more accessible to the less affluent countries. The aloe plant production methods may also produce proteins for cosmetics.

Transgenic Aloe Plants For Production Of Proteins And Related Methods
view source
US Patent:

20160160228, Jun 9, 2016
Filed:

Jan 28, 2016
Appl. No.:

15/009278
Inventors:

- Miami FL, US
Kevin LORICK - Kensington MD, US
Marisol PAGES - Santo Domingo, DO
Nicola J. LOWTHER - Washington DC, US
International Classification:

C12N 15/82
Abstract:

The present inventions provide transgenic aloe plants and recombinant constructs for transforming aloe plants, aspects of which, may be applied to other monocots. The recombinant constructs may include one or more DNA sequences encoding mammalian proteins and at least one promoter capable of directing the expression of recombinant proteins in an aloe plant. The present inventions also provide methods for constructing and reproducing a transgenic aloe plant. The present inventions include methods for transfection of an aloe plant with several genes of interest simultaneously. The aloe plant production methods of the inventions may provide the potential to inexpensively and more safely mass-produce some biologically active compounds including biopharmaceuticals for disease therapy, diagnosis and prevention, and is more accessible to the less affluent countries. The aloe plant production methods may also produce proteins for cosmetics.